Genetic Susceptibility and Familial Patterns in Multiple Sclerosis
Multiple sclerosis is presented in this review as a complex genetic disease rather than a disorder transmitted through a simple Mendelian pattern. Balcerac and Louapre emphasize that MS arises from an interaction between inherited susceptibility and environmental exposures, including Epstein–Barr virus infection, reduced sunlight exposure, smoking, and vitamin D deficiency. The article estimates that genetic and environmental factors each contribute approximately half of the overall risk of developing MS, underscoring that genetic predisposition is substantial but not deterministic.
The Central Role of the HLA Region
A major focus of the article is the human leukocyte antigen region, especially the HLA-DRB115:01 allele, which is described as the strongest genetic risk factor for MS. This allele belongs to the HLA-DR2 haplotype and is particularly common among Caucasian patients with MS. The review explains that HLA-DRB115:01 may contribute to disease susceptibility through immune cross-reactivity, especially involving Epstein–Barr virus antigens and myelin-related proteins, thereby linking genetic predisposition with a plausible autoimmune mechanism.
Beyond HLA: Polygenic Risk and Immune Pathways
Although HLA genes dominate MS genetic susceptibility, the review highlights that genome-wide association studies have identified more than 200 additional risk associations. These include variants related to immune regulation, such as IL7RA, IL2RA, TNF-alpha signaling, and other pathways involved in peripheral immune-cell function. The article therefore frames MS as a polygenic immune-mediated disease, in which many common variants each contribute small increments of risk rather than a single causative mutation.
Genotype–Phenotype Associations in MS
The authors also discuss whether genetic variants influence clinical presentation and disease severity. HLA-DRB115:01 is associated with earlier symptom onset, greater lesion burden, cortical atrophy, cognitive impairment, and disability in some studies. Other alleles, such as HLA-B44:02, may have protective associations, including fewer brain lesions and less cortical atrophy. However, the review stresses that genotype–phenotype correlations remain incomplete and are not yet sufficiently predictive for routine individualized prognosis.
Familial Multiple Sclerosis and Recurrence Risk
Familial MS is defined in the article as MS occurring in a patient with another affected relative within the third degree. The review reports that familial MS accounts for approximately 12.6% of MS cases worldwide. Risk increases with genetic proximity: monozygotic twins show the highest concordance, followed by siblings, children, and more distant relatives. This pattern supports a strong inherited component while also demonstrating that shared genes alone cannot fully explain disease occurrence.
Clinical Features of Familial Versus Sporadic MS
The article contrasts familial and sporadic MS and notes that earlier studies did not consistently identify phenotypic differences. More recent evidence, however, suggests that familial MS may be associated with multifocal onset, more relapses, earlier disability worsening, more severe long-term disability, and distinct MRI patterns, including greater brain and spinal cord lesion burden. The review also discusses parent–child and sibling concordance, particularly similarities in age at onset and, less consistently, disease course or severity.
Scientific and Clinical Implications
Balcerac and Louapre conclude that MS genetics has advanced substantially through GWAS and next-generation sequencing, yet translation into clinical practice remains limited. Genetic information may eventually improve risk estimation, patient counseling, pharmacogenomics, and understanding of disease heterogeneity. Nevertheless, the article argues that future research must integrate detailed clinical phenotyping, advanced MRI measures, familial studies, ancestry diversity, and treatment effects to clarify how inherited susceptibility shapes the real-world course of MS.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Ge, A., Sun, Y., Kiker, T., Zhou, Y., & Ye, K. (2023). A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis. Journal of neuroimmunology, 379, 578105.
